Back to top
more

Surmodics (SRDX)

(Delayed Data from NSDQ)

$41.80 USD

41.80
478,250

+0.02 (0.05%)

Updated Jul 23, 2024 04:00 PM ET

After-Market: $41.84 +0.04 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Sreyoshi Mukherjee headshot

3 Top Stocks From the Booming US Medical Products Industry

The U.S. Medical Products industry is sturdy on solid focus on technological advancement.

    GW Pharmaceuticals (GWPH) Catches Eye: Stock Jumps 5.9%

    GW Pharmaceuticals (GWPH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

      Medical - Products Stock Outlook: Short-Term Pain Inevitable

      Near-term growth prospects of medical products are being questioned due to trade war apprehensions and President Trump's imposition of fresh tariffs on about $200 billion on Chinese imports.

        Here's Why You Should Invest in Surmodics (SRDX) Stock Now

        Continuous focus on R&D and a raised guidance for fiscal 2018 make Surmodics (SRDX) a lucrative pick for investors.

          Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod

          The latest FDA approval for Baxter's (BAX) Actifuse Flow bone graft is likely to boost its Advanced Surgery segment.

            Why Is SurModics (SRDX) Up 19.9% Since Last Earnings Report?

            SurModics (SRDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

              Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries

              Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries

                Tirthankar Chakraborty headshot

                4 of the Best Efficient Stocks to Enrich Your Portfolio

                A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.

                  Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International

                  Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International

                    Tirthankar Chakraborty headshot

                    4 Winning Stocks With Solid Efficiency Level

                    A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.

                      Surmodics' (SRDX) IVD Unit Boosts Growth, R&D Focus Solid

                      Surmodics' (SRDX) strong focus on R&D to provide it a competitive edge in the MedTech space.

                        Surmodics (SRDX) Beats Q3 Earnings Estimates, Raises '18 View

                        Surmodics' (SRDX) third-quarter fiscal 2018 results benefit from increase in royalty and license fee revenues.

                          SurModics (SRDX) Tops Q3 Earnings and Revenue Estimates

                          SurModics (SRDX) delivered earnings and revenue surprises of 437.50% and 12.20%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

                            Sweta Killa headshot

                            5 Top Performing Stocks of the Best ETF of 1H2018

                            Inside the top performing stocks of the top ETF of the first half of 2018.

                              Zacks.com featured highlights include: Illumina, Lululemon, Surmodics and ConocoPhillips

                              Zacks.com featured highlights include: Illumina, Lululemon, Surmodics and ConocoPhillips

                                Tirthankar Chakraborty headshot

                                4 of the Best Efficient Stocks to Buy for Superb Returns

                                We have considered four popular ratios in order to find efficient companies that have the potential to provide impressive returns

                                  Here's Why You Must Add Surmodics (SRDX) to Your Portfolio

                                  Surmodics' (SRDX) efforts to improve research and development stature bode well.

                                    SYK or SRDX: Which is a Better Medical Product Stock?

                                    Stryker (SYK) and Surmodics' (SRDX) strong fundamentals and rising share price make them close contenders.

                                      Baxter (BAX) Soars to a 52-Week High, Time to Cash Out?

                                      Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.

                                        4 Medical Device Stocks with Solid Potential to Buy Now

                                        The Medical Device tax suspension spells good times for MedTech bigwigs.

                                          Surmodics (SRDX) Hits Fresh Highs: Is There Still Room to Run?

                                          Surmodics, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for SRDX for clues.

                                            Surmodics (SRDX) Gains From Consistent Efforts to Boost R&D

                                            Surmodics' (SRDX) consistent focus on research and development activities has been driving growth. The company is expected to make continued progress throughout the remainder of fiscal 2018.

                                              Zacks.com featured highlights include: Marine Products, Illumina, Chemed, Surmodics and MAM

                                              Zacks.com featured highlights include: Marine Products, Illumina, Chemed, Surmodics and MAM

                                                Baxter International (BAX) Hits a 52-Week High, Can the Run Continue?

                                                Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.

                                                  Tirthankar Chakraborty headshot

                                                  5 Top Efficient Stocks to Keep on Your Radar

                                                  We have considered four popular ratios in order to find efficient companies that have the potential to provide impressive returns